Abstract
Previous reports have demonstrated that gene transfer with the α, or pore-forming, subunit of the human Maxi-K channel (hSlo) restores the decline in erectile capacity observed in established rat models of diabetes and aging. Preliminary data from a human clinical trial also showed safety and potential efficacy in 11 men treated with the same plasmid construct expressing the Maxi-K channel. In all instances, the original plasmid was driven by the heterologous cytomegalovirus promoter which is broadly active in a wide variety of cell and tissue types. To more precisely determine the contribution of the corporal myocyte to the observed physiological effects in vivo, we report here our initial work using a distinct vector (pSMAA-hSlo) in which hSlo gene expression was driven off the mouse smooth muscle α-actin (SMAA) promoter. Specifically, older rats, with diminished erectile capacity, were given a single intracorporal injection with either 100 μg pVAX-hSlo or 10, 100 or 1000 μg pSMAA-hSlo, or vector or vehicle alone. Significantly increased intracavernous pressure (ICP) responses to cavernous nerve stimulation were observed for all doses of both plasmids encoding hSlo, relative to control injections. These data confirm and extend previous observations to document that smooth muscle cell-specific expression of hSlo in corporal tissue is both necessary and sufficient to restore erectile function in aging rats.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Araujo A, Mohr B, McKinlay J . Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 2004; 52: 1502–1509.
Marumo K, Nakashima J, Muria M . Age-related prevalence of erectile dysfunction in Japan: assessment by the international index of erectile function. Int J Urol 2001; 8: 53–59.
Melman A, Gingell JC . The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
Benet AE, Melman A . The epidemiology of erectile dysfunction. Urol Clin North Am 1995; 22: 699–709.
Garban H, Marquez D, Liping C, Rajfer J, Gonzalez-Cadavid N . Restoration of normal adult penile erectile response in aged rats by long term treatment with androgens. Bio Reprod 1995; 53: 1365–1372.
Lerner SE, Melman A, Christ GJ . A review of erectile dysfunction: new insights and more questions. J Urol 1993; 149: 1246–1255.
Melman A, Christ GJ . The hemodynamics of erection and the pharmacotherapies of erectile dysfunction. Heart Dis 2002; 4: 252–264.
Melman A, Christ GJ . Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am 2001; 28: 217–231, vii.
Wespes E . Smooth muscle pathology and erectile dysfunction. Int J Impot Res 2002; 14: S17–S21.
Ferrini M, Magee T, Vernet D, Rajfer J, Gonzalez-Cadavid N . Aging-related expression of inducible nitric oxide synthase and marker of tissue damage in the rat penis. Bio Reprod 2001; 64: 974–982.
Chang S, Hypolite JA, Changolkar A, Wein AJ, Chacko S, DiSanto ME . Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res 2003; 15: 53–62.
Li J, Wang G, Qin W, Yang Y . Effect of aging on the endothelial function of the penile corpus cavernosum in rats. Zonghua Nan Ke Xue 2004; 10: 824–826.
Korovkina VP, England SK . Detection and implications of potassium channel alterations. Vascul Pharmacol 2002; 38: 3–12.
Christ GJ, Rehman J, Day N, Salkoff L, Valcic M, Melman A et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol 1998; 275: H600–H608.
Melman A, Zhao W, Davies KP, Bakal R, Christ GJ . The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 2003; 170: 285–290.
Christ GJ, Day N, Sato Y, Zhao W, Sclanfani T, Bakal R et al. Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo. Am J Physiol Heart Circ Physiol 2004; 287: H1544–H1553.
Melman A, Bar-Chama N, McCullough A, Davies K, Christ G . The first human trial for gene transfer therapy for the treatment of erectile dysfunction: preliminary results. Eur Urol 2005; 48: 314–318.
Melman A, Bar-Chama N, McCullough A, Davies K, Christ G . hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial. Hum Gene Ther 2006; 18: 1165–1176.
Pritchard TJ, Parvatiyar M, Bullard DP, Lynch RM, Lorenz JN, Paul RJ . Transgenic mice expressing Na+-K+-ATPase in smooth muscle decreases blood pressure. Am J Physiol Heart Circ Physiol 2007; 293: H1172–H1182.
Knott AW, Juno RJ, Jarboe MD, Profitt SA, Erwin CR, Smith EP et al. Smooth muscle overexpression of IGF-I induces a novel adaptive response to small bowel resection. Am J Physiol Gastrointest Liver Physiol 2004; 287: G562–G570.
Gokturk C, Nilsson J, Nordquist J, Kristensson M, Svensson K, Soderberg C et al. Overexpression of semicarbazide-sensitive amine oxidase in smooth muscle cells leads to an abnormal structure of the aortic elastic laminas. Am J Pathol 2003; 163: 1921–1928.
Noonan WT, Qian J, Stuart WD, Clemens TL, Lorenz JN . Altered renal hemodynamics in mice overexpressing the parathyroid hormone (PTH)/PTH-related peptide type 1 receptor in smooth muscle. Endocrinology 2003; 144: 4931–4938.
Zhang M, Smith EP, Kuroda H, Banach W, Chernausek SD, Fagin JA . Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. J Biol Chem 2002; 277: 21285–21290.
Zhao G, Sutliff RL, Weber CS, Wang J, Lorenz J, Paul RJ et al. Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility. Endocrinology 2001; 142: 623–632.
Qian J, Lorenz JN, Maeda S, Sutliff RL, Weber C, Nakayama T et al. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology 1999; 140: 1826–1833.
Wang J, Niu W, Witte DP, Chernausek SD, Nikiforov YE, Clemens TL et al. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology 1998; 139: 2605–2614.
Nakano Y, Nishihara T, Sasayama S, Miwa T, Kamada S, Kakunaga T . Transcriptional regulatory elements in the 5′ upstream and first regions of the humans smooth muscle (aortic type) alpha-actin-encoding gene. Gene 1991; 99: 285–289.
Yang Z-H, Kitami Y, Takata Y, Okura T, Hiwada K . Targeted overexpression CCAAT/enhanced-binding protein-d evokes enhanced gene transcription of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Circ Res 2001; 89: 503–508.
Rolland A . Gene medicines: the end of the beginning? Adv Drug Deliv Rev 2005; 57: 669–673.
Szucik JC, Lewis AG, Marmer DJ, Lessard JL . Urogenital tract expression of enhanced green fluorescent in transgenic mice driven by a smooth muscle [gamma]-actin promoter. J Urol 2004; 171: 944–949.
Christ GJ, Liebert M . Proceedings of the Baltimore smooth muscle meeting: identifying research frontiers and priorities for the lower urinary tract. J Urol 2005; 173: 1406–1409.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dr A Melman and Dr GJ Christ are founders and directing members of Ion Channel Innovations, LLC, the sponsor of the preclinical studies and clinical trial.
Rights and permissions
About this article
Cite this article
Melman, A., Biggs, G., Davies, K. et al. Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat. Gene Ther 15, 364–370 (2008). https://doi.org/10.1038/sj.gt.3303093
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3303093
Keywords
This article is cited by
-
Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED
International Journal of Impotence Research (2012)
-
Emerging tools for erectile dysfunction: a role for regenerative medicine
Nature Reviews Urology (2012)
-
eNOS-uncoupling in age-related erectile dysfunction
International Journal of Impotence Research (2011)
-
Nucleic acid therapy for lifespan prolongation: Present and future
Journal of Biosciences (2011)
-
Emerging and Novel Therapeutic Approaches in the Treatment of Male Erectile Dysfunction
Current Urology Reports (2011)